197 related articles for article (PubMed ID: 21104860)
1. Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders.
Bachinski LL; Sirito M; Böhme M; Baggerly KA; Udd B; Krahe R
Muscle Nerve; 2010 Dec; 42(6):856-63. PubMed ID: 21104860
[TBL] [Abstract][Full Text] [Related]
2. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.
Bachinski LL; Baggerly KA; Neubauer VL; Nixon TJ; Raheem O; Sirito M; Unruh AK; Zhang J; Nagarajan L; Timchenko LT; Bassez G; Eymard B; Gamez J; Ashizawa T; Mendell JR; Udd B; Krahe R
Neuromuscul Disord; 2014 Mar; 24(3):227-40. PubMed ID: 24332166
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity.
Zhu B; Gulick T
Mol Cell Biol; 2004 Sep; 24(18):8264-75. PubMed ID: 15340086
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.
Santoro M; Masciullo M; Bonvissuto D; Bianchi ML; Michetti F; Silvestri G
Mol Cell Biochem; 2013 Aug; 380(1-2):259-65. PubMed ID: 23666741
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma.
Bai X; Wu L; Liang T; Liu Z; Li J; Li D; Xie H; Yin S; Yu J; Lin Q; Zheng S
J Cancer Res Clin Oncol; 2008 Jan; 134(1):83-91. PubMed ID: 17611778
[TBL] [Abstract][Full Text] [Related]
6. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.
Zhu B; Ramachandran B; Gulick T
J Biol Chem; 2005 Aug; 280(31):28749-60. PubMed ID: 15834131
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing dysregulation secondary to skeletal muscle regeneration.
Orengo JP; Ward AJ; Cooper TA
Ann Neurol; 2011 Apr; 69(4):681-90. PubMed ID: 21400563
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
Maiti D; Xu Z; Duh EJ
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
[TBL] [Abstract][Full Text] [Related]
9. Expression of myocyte enhancer factor-2 and downstream genes in ground squirrel skeletal muscle during hibernation.
Tessier SN; Storey KB
Mol Cell Biochem; 2010 Nov; 344(1-2):151-62. PubMed ID: 20617369
[TBL] [Abstract][Full Text] [Related]
10.
Bosè F; Renna LV; Fossati B; Arpa G; Labate V; Milani V; Botta A; Micaglio E; Meola G; Cardani R
Front Neurol; 2019; 10():992. PubMed ID: 31611837
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein Muscleblind-like 3 (MBNL3) disrupts myocyte enhancer factor 2 (Mef2) {beta}-exon splicing.
Lee KS; Cao Y; Witwicka HE; Tom S; Tapscott SJ; Wang EH
J Biol Chem; 2010 Oct; 285(44):33779-87. PubMed ID: 20709755
[TBL] [Abstract][Full Text] [Related]
12. Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.
Machuca-Tzili L; Thorpe H; Robinson TE; Sewry C; Brook JD
Hum Genet; 2006 Nov; 120(4):487-99. PubMed ID: 16927100
[TBL] [Abstract][Full Text] [Related]
13. Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice.
Wu H; Olson EN
J Clin Invest; 2002 May; 109(10):1327-33. PubMed ID: 12021248
[TBL] [Abstract][Full Text] [Related]
14. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice.
Xu J; Gong NL; Bodi I; Aronow BJ; Backx PH; Molkentin JD
J Biol Chem; 2006 Apr; 281(14):9152-62. PubMed ID: 16469744
[TBL] [Abstract][Full Text] [Related]
15. Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.
Vihola A; Sirito M; Bachinski LL; Raheem O; Screen M; Suominen T; Krahe R; Udd B
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):390-405. PubMed ID: 22758909
[TBL] [Abstract][Full Text] [Related]
16. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis.
Edmondson DG; Lyons GE; Martin JF; Olson EN
Development; 1994 May; 120(5):1251-63. PubMed ID: 8026334
[TBL] [Abstract][Full Text] [Related]
17. Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.
Wu W; de Folter S; Shen X; Zhang W; Tao S
PLoS One; 2011 Mar; 6(3):e17334. PubMed ID: 21394201
[TBL] [Abstract][Full Text] [Related]
18. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
Dodou E; Xu SM; Black BL
Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
[TBL] [Abstract][Full Text] [Related]
19. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis.
Karamboulas C; Dakubo GD; Liu J; De Repentigny Y; Yutzey K; Wallace VA; Kothary R; Skerjanc IS
J Cell Sci; 2006 Oct; 119(Pt 20):4315-21. PubMed ID: 17003108
[TBL] [Abstract][Full Text] [Related]
20. Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.
Vihola A; Bachinski LL; Sirito M; Olufemi SE; Hajibashi S; Baggerly KA; Raheem O; Haapasalo H; Suominen T; Holmlund-Hampf J; Paetau A; Cardani R; Meola G; Kalimo H; Edström L; Krahe R; Udd B
Acta Neuropathol; 2010 Apr; 119(4):465-79. PubMed ID: 20066428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
